{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-158327","form_type":"8-K","ticker":"RAPP","cik":"0002012593","company_name":"Rapport Therapeutics, Inc.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.403731+00:00","generated_at":"2026-06-01T05:24:30.084572+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Rapport Therapeutics closes private placement of 1,058,824 shares at $17.00 per share with existing stockholders","bullets":["Entered Stock Purchase Agreements with Sofinnova Venture Partners and affiliates of Goldman Sachs for 1,058,824 shares at $17.00/share, concurrent with IPO.","Private placement closed June 10, 2024; placement agents included Goldman Sachs, Jefferies, TD Securities, and Stifel.","Shares issued under Section 4(a)(2) exemption to institutional accredited investors; Sofinnova granted registration rights after one-year anniversary.","Filed third amended and restated certificate of incorporation and bylaws in connection with IPO effectiveness."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-158327","json":"https://secwatch.observer/filing/0001193125-24-158327.json","markdown":"https://secwatch.observer/filing/0001193125-24-158327.md","text":"https://secwatch.observer/filing/0001193125-24-158327.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2012593/000119312524158327/0001193125-24-158327-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2012593/000119312524158327/d60139d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:24:30.084572+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}